Sitaxsentan

( DrugBank: Sitaxsentan / KEGG DRUG: Sitaxentan )

1 disease

ID	Disease name (Link within this page)	Number of trials
86	Pulmonary arterial hypertension	21

86. Pulmonary arterial hypertension

Clinical trials : 1,205 / Drugs : 684 - (DrugBank : 124) / Drug target genes : 100 - Drug target pathways : 193

trials per page:

Showing 1 to 10 of 21 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01251848 (ClinicalTrials.gov)	January 2011	1/12/2010	Drug Interaction Between Ritonavir And Sitaxsentan	A Phase 1, Open Label, Randomized, Multiple Dose Study To Assess The Two-Way Drug Interaction Betwee ...	Pulmonary Arterial Hypertension	Drug: Sitaxentan;Drug: Ritonavir;Drug: Sitaxsentan	Pfizer	NULL	Withdrawn	21 Years	55 Years	Both	0	Phase 1	NULL
2	NCT01251835 (ClinicalTrials.gov)	December 2010	1/12/2010	Effect Of Rifampin On Pharmacokinetics Of Sitaxsentan	A Phase 1, Open Label, Fixed Sequence Design, Multiple Dose Study To Assess The Effect Of Rifampin O ...	Pulmonary Arterial Hypertension	Drug: Sitaxsentan alone;Drug: Sitaxsentan;Drug: Rifampin	Pfizer	NULL	Withdrawn	21 Years	55 Years	Both	0	Phase 1	NULL
3	NCT01244620 (ClinicalTrials.gov)	November 2010	15/11/2010	A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between SitaxsentanAnd Sildenafil, And Between S ...	A Phase 1, Open Label, Randomized, Four Period, Crossover, Multiple Dose Study To Assess The Pharmac ...	Pulmonary Arterial Hypertension	Drug: sitaxentan;Drug: tadalafil;Drug: sitaxsentan;Drug: sildenafil	Pfizer	NULL	Terminated	21 Years	55 Years	All	16	Phase 1	Singapore
4	NCT00796510 (ClinicalTrials.gov)	July 2010	20/11/2008	Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjec ...	A Phase 3, Multi-Center, Open Label Study To Evaluate The Long-Term Safety Of Monotherapy Sitaxsenta ...	Pulmonary Arterial Hypertension;Pulmonary Hypertension	Drug: Sitaxsentan;Drug: Sitaxsentan and Sildenafil	Pfizer	NULL	Terminated	16 Years	80 Years	All	3	Phase 3	United States;Romania;Ukraine;Argentina;Bulgaria;Chile;China;Colombia;Costa Rica;Czech Republic;Domi ...
5	EUCTR2008-005885-30-CZ (EUCTR)	12/01/2010	10/12/2008	A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED,SAFETY AND EFFICACY STUDY OF SI ...	A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED,SAFETY AND EFFICACY STUDY OF SI ...	Pulmonary arterial hypertension MedDRA version: 9.1;Level: HLT;Classification code 10037401;Term: Pu ...	Trade Name: Thelin INN or Proposed INN: SITAXSENTAN SODIUM	Pfizer Ltd	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 3	Czech Republic;Bulgaria
6	EUCTR2008-005886-78-CZ (EUCTR)	12/01/2010	10/12/2008	A PHASE 3, MULTI-CENTER, OPEN LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY OF MONOTHERAPY SITAXSENTA ...	A PHASE 3, MULTI-CENTER, OPEN LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY OF MONOTHERAPY SITAXSENTA ...	PULMONARY ARTERIAL HYPERTENSION MedDRA version: 9.1;Level: HLT;Classification code 10037401;Term: Pu ...	Trade Name: Thelin INN or Proposed INN: SitaxsentanSodium Trade Name: Revatio INN or Proposed INN: Sild ...	Pfizer Ltd.	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 3	Czech Republic;Bulgaria
7	EUCTR2008-005887-14-CZ (EUCTR)	12/01/2010	10/12/2008	A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, EFFICACY AND SAFETY STUDY OF MONOTHERAPY SITAXSEN ...	A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, EFFICACY AND SAFETY STUDY OF MONOTHERAPY SITAXSEN ...	Pulmonary Arterial Hypertension MedDRA version: 9.1;Level: LLT;Classification code 10064911;Term: Pu ...	Trade Name: Thelin INN or Proposed INN: SitaxsentanSodium Trade Name: Revatio INN or Proposed INN: Sild ...	Pfizer Ltd.	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 3	Czech Republic;Bulgaria
8	NCT01445873 (ClinicalTrials.gov)	December 1, 2009	30/9/2011	Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertens ...	NON-INTERVENTIONAL (NI) DRUG STUDY PROTOCOL: THREE-COUNTRY PILOT STUDY FOR RETROSPECTIVE CHART REVIE ...	Pulmonary Arterial Hypertension	Drug: Sitaxentan sodium	Pfizer	NULL	Completed	18 Years	N/A	All	36		NULL
9	EUCTR2008-005885-30-BG (EUCTR)	25/06/2009	19/06/2009	A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED,SAFETY AND EFFICACY STUDY OF SI ...	A PHASE 3, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED,SAFETY AND EFFICACY STUDY OF SI ...	Pulmonary arterial hypertension MedDRA version: 13.1;Level: HLT;Classification code 10037401;Term: P ...	Trade Name: Thelin INN or Proposed INN: SITAXSENTAN SODIUM	Pfizer Inc., 235 East 42nd Street, New York, NY 10017	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 3	Czech Republic;Bulgaria
10	EUCTR2008-005886-78-BG (EUCTR)	25/06/2009	19/06/2009	A PHASE 3, MULTI-CENTER, OPEN LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY OF MONOTHERAPY SITAXSENTA ...	A PHASE 3, MULTI-CENTER, OPEN LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY OF MONOTHERAPY SITAXSENTA ...	PULMONARY ARTERIAL HYPERTENSION MedDRA version: 9.1;Level: HLT;Classification code 10037401;Term: Pu ...	Trade Name: Thelin INN or Proposed INN: SitaxsentanSodium Trade Name: Revatio INN or Proposed INN: Sild ...	Pfizer Inc., 235 East 42nd Street, New York, NY 10017	NULL	Not Recruiting			Female: yes Male: yes	150	Phase 3	Czech Republic;Bulgaria

First Previous1 2 3Next Last